408 related articles for article (PubMed ID: 19088064)
1. Defects in Jak-STAT-mediated cytokine signals cause hyper-IgE syndrome: lessons from a primary immunodeficiency.
Minegishi Y; Karasuyama H
Int Immunol; 2009 Feb; 21(2):105-12. PubMed ID: 19088064
[TBL] [Abstract][Full Text] [Related]
2. Hyper-IgE syndrome.
Minegishi Y
Curr Opin Immunol; 2009 Oct; 21(5):487-92. PubMed ID: 19717292
[TBL] [Abstract][Full Text] [Related]
3. Cutaneous manifestations of Hyper IgE syndrome.
Minegishi Y; Saito M
Allergol Int; 2012 Jun; 61(2):191-6. PubMed ID: 22441639
[TBL] [Abstract][Full Text] [Related]
4. A novel mutation in the signal transducer and activator of transcription 3 (STAT3) gene, in hyper-IgE syndrome.
Papanastasiou AD; Mantagos S; Papanastasiou DA; Zarkadis IK
Mol Immunol; 2010 Apr; 47(7-8):1629-34. PubMed ID: 20149460
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of the immunological abnormalities in hyper-IgE syndrome.
Minegishi Y; Saito M
Ann N Y Acad Sci; 2011 Dec; 1246():34-40. PubMed ID: 22236428
[TBL] [Abstract][Full Text] [Related]
6. Hyper IgE (Job's) syndrome: a primary immune deficiency with oral manifestations.
Freeman AF; Domingo DL; Holland SM
Oral Dis; 2009 Jan; 15(1):2-7. PubMed ID: 19036057
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis.
Schimke LF; Sawalle-Belohradsky J; Roesler J; Wollenberg A; Rack A; Borte M; Rieber N; Cremer R; Maass E; Dopfer R; Reichenbach J; Wahn V; Hoenig M; Jansson AF; Roesen-Wolff A; Schaub B; Seger R; Hill HR; Ochs HD; Torgerson TR; Belohradsky BH; Renner ED
J Allergy Clin Immunol; 2010 Sep; 126(3):611-7.e1. PubMed ID: 20816194
[TBL] [Abstract][Full Text] [Related]
8. Hyper-IgE syndrome is not associated with defects in several candidate toll-like receptor pathway genes.
Hawn TR; Ozinsky A; Williams LM; Rodrigues S; Clark A; Pham U; Hill HR; Ochs H; Aderem A; Liles WC
Hum Immunol; 2005 Jul; 66(7):842-7. PubMed ID: 16112032
[TBL] [Abstract][Full Text] [Related]
9. Reduced expression of chemoattractant receptors by polymorphonuclear leukocytes in Hyper IgE Syndrome patients.
Mintz R; Garty BZ; Meshel T; Marcus N; Katanov C; Cohen-Hillel E; Ben-Baruch A
Immunol Lett; 2010 May; 130(1-2):97-106. PubMed ID: 20005258
[TBL] [Abstract][Full Text] [Related]
10. [Hyper-IgE recurrent infection syndrome: pathogenesis, diagnosis and therapeutic management].
Guisado Vasco P; Fraile Rodríguez G; Arechaga Uriarte S
Rev Clin Esp; 2011 Nov; 211(10):520-6. PubMed ID: 21700278
[TBL] [Abstract][Full Text] [Related]
11. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome.
Minegishi Y; Saito M; Tsuchiya S; Tsuge I; Takada H; Hara T; Kawamura N; Ariga T; Pasic S; Stojkovic O; Metin A; Karasuyama H
Nature; 2007 Aug; 448(7157):1058-62. PubMed ID: 17676033
[TBL] [Abstract][Full Text] [Related]
12. Novel and recurrent STAT3 mutations in hyper-IgE syndrome patients from different ethnic groups.
Jiao H; Tóth B; Erdos M; Fransson I; Rákóczi E; Balogh I; Magyarics Z; Dérfalvi B; Csorba G; Szaflarska A; Megarbane A; Akatcherian C; Dbaibo G; Rajnavölgyi E; Hammarström L; Kere J; Lefranc G; Maródi L
Mol Immunol; 2008 Nov; 46(1):202-6. PubMed ID: 18706697
[TBL] [Abstract][Full Text] [Related]
13. Clinical features, STAT3 gene mutations and Th17 cell analysis in nine children with hyper-IgE syndrome in mainland China.
Zhang LY; Tian W; Shu L; Jiang LP; Zhan YZ; Liu W; Zhao XD; Cui YX; Tang XM; Wang M; Wu DQ; Yang XQ
Scand J Immunol; 2013 Sep; 78(3):258-65. PubMed ID: 23659370
[TBL] [Abstract][Full Text] [Related]
14. Human tyrosine kinase 2 deficiency reveals its requisite roles in multiple cytokine signals involved in innate and acquired immunity.
Minegishi Y; Saito M; Morio T; Watanabe K; Agematsu K; Tsuchiya S; Takada H; Hara T; Kawamura N; Ariga T; Kaneko H; Kondo N; Tsuge I; Yachie A; Sakiyama Y; Iwata T; Bessho F; Ohishi T; Joh K; Imai K; Kogawa K; Shinohara M; Fujieda M; Wakiguchi H; Pasic S; Abinun M; Ochs HD; Renner ED; Jansson A; Belohradsky BH; Metin A; Shimizu N; Mizutani S; Miyawaki T; Nonoyama S; Karasuyama H
Immunity; 2006 Nov; 25(5):745-55. PubMed ID: 17088085
[TBL] [Abstract][Full Text] [Related]
15. Genetic origins of hyper-IgE syndrome.
Minegishi Y; Karasuyama H
Curr Allergy Asthma Rep; 2008 Sep; 8(5):386-91. PubMed ID: 18682102
[TBL] [Abstract][Full Text] [Related]
16. Autosomal recessive hyperimmunoglobulin E syndrome: a distinct disease entity.
Renner ED; Puck JM; Holland SM; Schmitt M; Weiss M; Frosch M; Bergmann M; Davis J; Belohradsky BH; Grimbacher B
J Pediatr; 2004 Jan; 144(1):93-9. PubMed ID: 14722525
[TBL] [Abstract][Full Text] [Related]
17. Successful long-term correction of autosomal recessive hyper-IgE syndrome due to DOCK8 deficiency by hematopoietic stem cell transplantation.
Bittner TC; Pannicke U; Renner ED; Notheis G; Hoffmann F; Belohradsky BH; Wintergerst U; Hauser M; Klein B; Schwarz K; Schmid I; Albert MH
Klin Padiatr; 2010 Nov; 222(6):351-5. PubMed ID: 21058221
[TBL] [Abstract][Full Text] [Related]
18. Reduced memory B cells in patients with hyper IgE syndrome.
Speckmann C; Enders A; Woellner C; Thiel D; Rensing-Ehl A; Schlesier M; Rohr J; Jakob T; Oswald E; Kopp MV; Sanal O; Litzman J; Plebani A; Pietrogrande MC; Franco JL; Espanol T; Grimbacher B; Ehl S
Clin Immunol; 2008 Dec; 129(3):448-54. PubMed ID: 18835223
[TBL] [Abstract][Full Text] [Related]
19. Severely impaired IL-12/IL-18/IFNgamma axis in patients with hyper IgE syndrome.
Netea MG; Kullberg BJ; van der Meer JW
Eur J Clin Invest; 2005 Nov; 35(11):718-21. PubMed ID: 16269022
[TBL] [Abstract][Full Text] [Related]
20. Hyper-IgE syndromes.
Grimbacher B; Holland SM; Puck JM
Immunol Rev; 2005 Feb; 203():244-50. PubMed ID: 15661034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
